Methane is one of the most abundant gases on Earth — and one of the most frustrating. Burning it for energy releases CO₂. Converting it into something useful has proven stubbornly difficult because the molecule is chemically inert, refusing to react easily with most catalysts.
Now a research team at the University of Santiago de Compostela has cracked a problem chemists have struggled with for decades: they've developed a way to turn methane directly into pharmaceutical-grade chemical compounds — including, in a landmark first, a hormone therapy drug called dimestrol.
The study, published in Science Advances, describes how the team designed a specialised iron catalyst that activates methane at room temperature and converts it into versatile 'building blocks' through a process called allylation — attaching a chemical fragment that gives the methane molecule a functional handle for further reactions.
The catalyst works by controlling free radical reactions that previously caused side effects and reduced efficiency. By engineering the catalyst's molecular structure precisely, the team tamed these unwanted reactions, achieving selective, high-yield transformations that were previously impossible.
The result: methane, normally burned as a fuel, can now serve as a raw material for high-value products — pharmaceuticals, agricultural chemicals, industrial compounds — without releasing greenhouse gases in the process.
The lead researcher, Martín Fañanás, described the achievement as 'an important step toward a more sustainable and circular chemical economy.'
The implications are substantial. Natural gas infrastructure already distributes methane globally. If a fraction of it can be redirected into chemical synthesis rather than combustion, the economics of clean manufacturing change significantly. Industries that currently rely on petroleum-derived feedstocks could transition to methane-based alternatives.
And the fact that a complex non-steroidal estrogen used in hormone therapy was synthesised directly from methane in a landmark demonstration isn't just a technical curiosity — it's proof of concept for an entirely new supply chain for medicines.
Turning a greenhouse gas into a medicine. Chemistry doesn't get much more satisfying than that. ⚗️